News

The patent covers compounds including Triolex and formulations that contain the drug or the other claimed compounds. Harbor BioSciences said that Triolex is a compound for the treatment

Boiron claimed that the launch is a result of the success of Chestal’s counterpart, Children’s Chestal, which was released two years ago amid concerns over the safety of

The service utilises short tandem repeat (STR) profiling, a widely used technique established in forensic science. In a quest to discover new therapeutic drugs and drug targets, cell

Healthmed said that Virtual Vantage allows an interface between handheld computers, such as the iPad and stationary computers, and has the capacity to create access the health industry

For the third quarter ended 31 July 2010, Renhuang Pharma’s net income grew 115.8% to $1.5m, or $0.04 per diluted share, from $0.7m, or $0.02 per diluted share

As per the pact, OctoPlus is expected to develop a controlled release formulation of an undisclosed compound using its proprietary drug delivery technology PolyActive, a biodegradable polymeric drug

Under the 4-year agreement, the KIF6 test kit manufactured by Celera, will be distributed by Abbott in the European Union and other geographic areas excluding the US. The

Ligand is expected to receive an upfront payment and continue to be entitled to receive potential future milestone and royalty payments. Ligand Pharma president and CEO John Higgins

The company has posted a operating loss of £6.91m the six months ended 2010, compared to operating loss of £3.61m, for the comparable period in 2009. Silence Therapeutics